<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">64508</article-id><article-id pub-id-type="doi">10.7554/eLife.64508</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Microbiology and Infectious Disease</subject></subj-group></article-categories><title-group><article-title>SARS-CoV-2 entry into human airway organoids is serine protease-mediated and facilitated by the multibasic cleavage site</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-213333"><name><surname>Mykytyn</surname><given-names>Anna Z</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-7188-6871</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-213862"><name><surname>Breugem</surname><given-names>Tim I</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-213863"><name><surname>Riesebosch</surname><given-names>Samra</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-213906"><name><surname>Schipper</surname><given-names>Debby</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-213865"><name><surname>van den Doel</surname><given-names>Petra B</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-103584"><name><surname>Rottier</surname><given-names>Robbert J</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-9291-4971</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-205629"><name><surname>Lamers</surname><given-names>Mart M</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-1431-4022</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-205628"><name><surname>Haagmans</surname><given-names>Bart L</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-6221-2015</contrib-id><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-2"/><xref ref-type="other" rid="par-3"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution content-type="dept">Viroscience</institution>, <institution>Erasmus MC</institution>, <addr-line><named-content content-type="city">Rotterdam</named-content></addr-line>, <country>Netherlands</country></aff><aff id="aff2"><institution content-type="dept">Pediatric Surgery/Cell Biology</institution>, <institution>Erasmus MC</institution>, <addr-line><named-content content-type="city">Rotterdam</named-content></addr-line>, <country>Netherlands</country></aff><aff id="aff3"><institution content-type="dept">Viroscience Department</institution>, <institution>Erasmus MC</institution>, <addr-line><named-content content-type="city">Rotterdam</named-content></addr-line>, <country>Netherlands</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-6168"><name><surname>Marsh</surname><given-names>Mark</given-names></name><role>Reviewing editor</role><aff><institution>University Coillege London</institution>, <country>United Kingdom</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>b.haagmans@erasmusmc.nl</email> (BH);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>04</day><month>01</month><year>2021</year></pub-date><volume>10</volume><elocation-id>e64508</elocation-id><history><date date-type="received"><day>31</day><month>10</month><year>2020</year></date><date date-type="accepted"><day>31</day><month>12</month><year>2020</year></date></history><permissions><copyright-statement>Â© 2020, Mykytyn et al</copyright-statement><copyright-year>2020</copyright-year><copyright-holder>Mykytyn et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-64508-v1.pdf"/><abstract><p>Coronavirus entry is mediated by the spike protein which binds the receptor and mediates fusion after cleavage by host proteases. The proteases that mediate entry differ between cell lines and it is currently unclear which proteases are relevant <italic>in vivo</italic>. A remarkable feature of the SARS-CoV-2 spike is the presence of a multibasic cleavage site (MBCS), which is absent in the SARS-CoV spike. Here, we report that the SARS-CoV-2 spike MBCS increases infectivity on human airway organoids (hAOs). Compared with SARS-CoV, SARS-CoV-2 entered faster into Calu-3 cells, and more frequently formed syncytia in hAOs. Moreover, the MBCS increased entry speed and plasma membrane serine protease usage relative to cathepsin-mediated endosomal entry. Blocking serine proteases, but not cathepsins, effectively inhibited SARS-CoV-2 entry and replication in hAOs. Our findings demonstrate that SARS-CoV-2 enters relevant airway cells using serine proteases, and suggest that the MBCS is an adaptation to this viral entry strategy.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Viruses</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100003246</institution-id><institution>Nederlandse Organisatie voor Wetenschappelijk Onderzoek</institution></institution-wrap></funding-source><award-id>0.22.005.032</award-id><principal-award-recipient><name><surname>Haagmans</surname><given-names>Bart L</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001826</institution-id><institution>ZonMw</institution></institution-wrap></funding-source><award-id>10150062010008</award-id><principal-award-recipient><name><surname>Haagmans</surname><given-names>Bart L</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution>Health Holland</institution></institution-wrap></funding-source><award-id>LSHM19136</award-id><principal-award-recipient><name><surname>Haagmans</surname><given-names>Bart L</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>All data generated or analysed during this study are included in the manuscript and supporting files</p></sec><supplementary-material><ext-link xlink:href="elife-64508-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>